Lemaitre Vascular (LMAT) | Stock Overview & Key Data
Lemaitre Vascular Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $118.12 on April 14, 2026
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Lemaitre Vascular
LMAT
|
2.59B Mid-cap | -3.35% | -5.54% | -17.00% | 11.05% | 14.66% | 13.35% | 37.54% | 49.26% | 549.89% | 1,209.97% | 1,325.74% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
| 9.38B Mid-cap | 8.16% | 20.29% | 21.84% | 6.55% | 6.72% | -31.87% | -54.01% | -74.19% | -53.06% | -34.17% | 1.07% | |
|
AptarGroup
ATR
|
7.99B Mid-cap | 5.49% | 2.97% | -8.50% | -3.47% | -3.64% | -22.12% | 0.49% | -15.97% | 54.18% | 133.20% | 364.56% |
|
Repligen
RGEN
|
7.49B Mid-cap | 4.42% | 27.22% | 13.69% | -18.50% | -20.37% | 2.41% | -17.06% | -33.82% | 517.16% | 3,568.26% | 4,563.93% |
Ownership & Short Interest
Calculate Your Lemaitre Vascular Investment Returns
Long-Term Investment Performance Analysis
Lemaitre Vascular stock price in Jul 2016 was $14.41, A $1,000.00 lump sum investment in Lemaitre Vascular made 9 years ago would be worth approximately $6,378.90 today, representing a exceptional return of 537.89%. This translates to an annualized return (CAGR) of 20.56%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is LMAT's 52-week high and low?
- In the last 52 weeks, Lemaitre Vascular reached a high of $118.01 (on April 14, 2026) and a low of $79.01 (on August 1, 2025).
- What is the market cap and P/E ratio for LMAT?
- Curious about Lemaitre Vascular's size and valuation? Its market capitalization stands at 2.59B. When it comes to valuation, the P/E ratio (trailing twelve months) is 44.80, and the forward P/E (looking ahead) is 35.45.
- Does LMAT pay dividends? If so, what's the yield?
- Yes, Lemaitre Vascular is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.97%, and the company has paid an average of $0.75 per share annually over the past 3 years.
- Who are Lemaitre Vascular's main competitors or similar companies to consider before investing?
When looking at Lemaitre Vascular, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% Baxter International
BAX9.38B Healthcare Medical Instruments & Supplies -31.87% -54.01% AptarGroup
ATR7.99B Healthcare Medical Instruments & Supplies -22.12% 0.49% Repligen
RGEN7.49B Healthcare Medical Instruments & Supplies 2.41% -17.06% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lemaitre Vascular Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Lemaitre Vascular's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.80%, the Debt to Equity ratio from the most recent quarter is 47.16, and its Gross Profit Margin stands at 71.66%.
- What is the recent revenue and earnings growth for LMAT?
- Looking at Lemaitre Vascular's growth, its revenue over the trailing twelve months (TTM) was $250M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.70%, and quarterly earnings saw a YoY growth of 39.30%.
- How much of LMAT stock is held by insiders and institutions?
- Wondering who owns Lemaitre Vascular stock? Company insiders (like executives and directors) hold about 6.89% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 97.09%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.